Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province

Abstract

Introduction: The World Health Organization identified Pharmaceutical and Therapeutics Committees (PTCs) at district and hospital levels as one of the pivotal models to promote rational use of medicines (RUM). This is endorsed by the Government in South Africa. Formulary development and management is one of the main functions of PTCs. This study aimed to describe the formulary management activities among PTCs in public hospitals in Gauteng Province, South Africa, following initiatives to promote RUM in South Africa. Methods: Qualitative, nonparticipatory, observational study, observing 26 PTC meetings. Data were coded and categorized using NVivo9 ® qualitative data analysis software. Themes and sub-themes were developed. The themes and sub-themes on formulary management are the principal focus of this paper. Results: More than half of the observed PTCs reviewed their formulary lists. There was variation in the review process among institutions providing different levels of care. Various aspects were considered for formulary management especially requests for medicines to be added. These included cost considerations (mainly focusing on acquisition costs), evidence-based evaluation of clinical trials, patient safety, clinical experience and changes in the National Essential Medicines List (NEML). The tertiary PTCs mostly dealt with applications for new non-EML medicines, while PTCs in the other hospitals mainly requested removal or addition of EML medicines to the list. Conclusion: This is the first study from Gauteng Province, South Africa, reporting on how decisions are actually taken to include or exclude medicines onto formularies within public sector hospitals providing different levels of care. Various approaches are adopted at different levels of care when adding to-or removing medicines from the formulary lists. Future programs should strengthen PTCs in specialized aspects of formulary management. A more structured approach to formulary review at the local PTC level

Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications

“…99 Examples include laws banning the dispensing of antibiotics in pharmacies without a prescription as well as national policies outlining the existence of DTCs in hospitals as currently seen in South Africa. 105 , 114 …”

National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis

“…Odoch and colleagues found that domestic health changes such as the devolution of health services had influenced NML updates [ 16 ]. Implementation can be particularly challenging in decentralized health systems that enable autonomy for medicine selection and use within regions and hospitals, even when a national framework for essential medicines is in place [ 5 , 20 , 44 ]. Several studies described inconsistencies between NMLs and how they are implemented at a regional or hospital level at the discretion of local doctors [ 5 , 41 , 42 , 44 ].…”

“…WHO recommends that all countries formulate and implement a comprehensive national medicines policy to improve access to safe and effective medicines of good quality [ 4 ]. A country’s NML is a government-approved list of medicines, which can often be adapted and implemented as a local formulary, or as a secondary list to the NML “tertiary list” [ 5 ]. The NML is intended to guide public sector procurement and supply, reimbursement schemes, medicine donations, and local production [ 6 ].…”

Perceptions, Expectations, and Experience of Physicians About Pharmacists and Pharmaceutical Care Services in Pakistan: Findings and Implications

“…Pharmacists can also help in critical areas such as medication taking and adherence in ambulatory care, especially where health literacy is an issue, treat minor ailments and enhance appropriate prescribing and dispensing of antibiotics for infections such as upper respiratory tract infections (Abdulsalim et al, 2018;Rampamba et al, 2019;Godman et al, 2020a;Godman et al, 2020b;Ogunleye et al, 2020;Selvaraj et al, 2020). Besides, pharmacists in both hospitals and the community can promote pharmacovigilance activities, which is a concern in LMICs (Terblanche et al, 2017;Haines et al, 2020), as well as have a vital role as members of Drug and Therapeutic Committees (DTCs) guiding physicians and suggesting alternative treatments when there are shortages of medicines (Matlala et al, 2017;Terblanche et al, 2018;Matlala et al, 2020;Modisakeng et al, 2020). Consequently, this traditional relationship between physicians and pharmacists needs reassessing to enhance the effectiveness, safety, and adherence to medicines prescribed and dispensed.…”

“…In Australia, pharmacists are also providing consultative services to patients upon referral from their physicians (Tan et al, 2014), and in the United States of America, pharmacists are part of multidisciplinary teams in intensive care units enhancing patient outcomes (Preslaski et al, 2013). This is changing as seen in South Africa with their increasing role in DTC and other activities (Matlala et al, 2017;Terblanche et al, 2018;Matlala et al, 2020;Modisakeng et al, 2020) and in Kenya where hospital pharmacists are introducing new practices to improve the administration of oncology medicines (Kurgat et al, 2020).…”